Peer Recovery Support for Substance Use Disorders
(P2P Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist young adults aged 18-25 who are beginning outpatient treatment for substance use issues, such as opiate addiction. It tests whether adding peer recovery support—a program led by individuals with lived recovery experience—can help retain participants in treatment and reduce dropout rates. Clinics will either maintain their usual services or incorporate this new peer support enhancement. Young adults between 18 and 25 who are starting outpatient treatment for a substance use problem may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative support methods that could enhance the recovery journey.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this peer recovery support enhancement is safe for emerging adults?
Research shows that peer recovery support services are generally safe for people with substance use disorders. These services involve support from individuals who have successfully completed recovery. Studies indicate that people respond well to these services, which help them remain in treatment and reduce dropout rates.
No major reports of negative effects linked to peer recovery support appear in the available studies. This suggests that these services are safe. They have been used in various settings without significant safety issues. Overall, peer recovery support services have a strong safety record in similar situations.12345Why are researchers excited about this trial?
Researchers are excited about the Peer Recovery Support-Delivered Dropout Prevention enhancement because it offers a unique approach to tackling substance use disorders. Unlike traditional treatments, which often rely on medication-assisted therapy or individual counseling, this method incorporates peer support to help prevent dropout from treatment programs. By involving individuals who have successfully navigated recovery themselves, this approach fosters a sense of community and understanding, which can be crucial for maintaining engagement. The hope is that this enhancement will lead to better retention in treatment and ultimately, more successful recovery outcomes.
What evidence suggests that the Peer Recovery Support-Delivered Dropout Prevention enhancement is effective for reducing dropout in substance use disorder treatment?
Research has shown that peer support can significantly aid individuals with substance use problems. One study found that participants who received peer support reduced their substance use from 30% to 16%, while those without support increased their use. Another review found that peer support lowered relapse rates and extended treatment duration. In this trial, participants in one arm will receive Peer Recovery Support-Delivered Dropout Prevention alongside usual services. A report indicated that 88.6% of individuals in a similar peer support program continued methadone treatment, nearly 29% more than those without support. These findings suggest that peer support can help young adults adhere to their treatment and reduce dropout rates.26789
Who Is on the Research Team?
Kristyn Zajac, PhD
Principal Investigator
UConn Health
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-25 who are starting outpatient treatment for substance use issues. It's designed to help them stick with their treatment program and not drop out early.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Usual Services
Clinics deliver their normal outpatient services
Dropout Prevention Enhancement
Peer recovery support-delivered dropout prevention enhancement added to usual services
Follow-up
Participants are monitored for dropout rates and service utilization
What Are the Treatments Tested in This Trial?
Interventions
- Peer Recovery Support-Delivered Dropout Prevention enhancement
Find a Clinic Near You
Who Is Running the Clinical Trial?
UConn Health
Lead Sponsor
University of Texas at Austin
Collaborator
Oregon Social Learning Center
Collaborator